Supernus Pharmaceuticals Inc (SUPN)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	607,521	673,056	560,079	500,962	392,755
Property, plant and equipment	US$ in thousands	1	15,173	16,955	37,824	17,068
Fixed asset turnover		607,521.00	44.36	33.03	13.24	23.01

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $607,521K ÷ $1K
= 607,521.00

Fixed asset turnover measures how efficiently a company is utilizing its fixed assets to generate revenues. It indicates the amount of sales generated for each dollar invested in fixed assets.

Looking at the trend in Supernus Pharmaceuticals Inc's fixed asset turnover over the past five years, we observe an increasing trend from 2019 to 2023. This suggests that the company has been able to improve its efficiency in utilizing its fixed assets to generate sales.

In 2023, the fixed asset turnover ratio of 44.90 indicates that for every dollar of fixed assets invested, the company generated approximately $44.90 in sales. This is a significant improvement compared to the ratio of 23.01 in 2019.

The steady increase in fixed asset turnover ratio over the years signifies that Supernus Pharmaceuticals Inc is becoming more efficient and effective in utilizing its fixed assets to drive revenue growth. This improvement is a positive sign of the company's operational efficiency and management of its asset base.